Formulation Development and Evaluation of Sustained Release Microsphere of Levetiracetam
The aim of the present work was to develop and evaluate of oral microsphere of Levetiracetam to reduce the frequency of dosing by achieving 12 hours sustained drug release. The microsphere formed will also mask the bitter taste of the drug and thus increase the compatibility of the drug with the pat...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutical sciences review and research 2021-12, Vol.71 (2) |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of the present work was to develop and evaluate of oral microsphere of Levetiracetam to reduce the frequency of dosing by
achieving 12 hours sustained drug release. The microsphere formed will also mask the bitter taste of the drug and thus increase the
compatibility of the drug with the patients. Levetiracetam is a second-generation anti-epileptic agent useful in the treatment of partial
onset and monoclinic seizures. It has a short half life of 7 hours and its recommended dose is 500 mg twice a daily. Microspheres are
suitable drug delivery system for such drug candidate. For these reasons it is must to formulate a suitable dosage form by which it
will be easier to administer the dose and also to get a sustained drug release hence microsphere was prepared using solvent
evaporation method. Preformulation studies were carried out to rule out any drug polymer interaction by FTIR technique. In this
study formulation was done solvent evaporation method using different percentage of HPMC– K 100, HPMC- K 15 and coated with
Eudragit S100. Drug, polymer and physical mixture were evaluated for in compatibility study by Fourier transforms infrared
spectroscopy. All the batches of microsphere (F1 to F5) were subjected for in vitro dissolution. Microsphere was evaluated for surface
morphology, micromeritics properties, entrapment efficiency and in vitro drug release. The entrapment efficiency of microsphere
ranged from 71.16%-73.66%. The size of the prepared microsphere ranges between 42.8 µm to 55.64 µm which was found to increase
with increase in RPM at same polymer ratio. Micromeritics studies showed good flow properties. Among the microsphere batches, F5 was observed as an optimized batch as its formulation with polymer i.e. Eudragit-S 100 and HPMC-K 100 was found to be release in
sustained manner. The F-5 batch shows is 79.45% drug release at the end of 7 hrs and its stability study indicate that these
microspheres were stable at selected temperature and humidity |
---|---|
ISSN: | 0976-044X 0976-044X |
DOI: | 10.47583/ijpsrr.2021.v71i02.026 |